Chat about Allergy Thera. accounts information. See how Allergy Thera. is performing financially.

Allergy Thera. Accounts Summary


Date of Accounts 20232022202120212020
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement29-06-202329-06-202230-06-202129-06-202130-06-2020
Revenue60.9572.7784.3384.3378.20
Operating Profit / Loss-36.13-12.244.034.038.31
Net Interest-13.70-0.41-0.37-0.37-0.24
Pre Tax Profit-49.83-12.663.663.668.07
Post Tax Profit-51.03-13.782.892.897.06
Profit for the Period-51.03-13.782.892.897.06
Equity Holders of Parent Company-51.03-13.782.892.897.06
Minority Interestsn/an/an/an/an/a
      
Continuing EPS     
Earnings per Share (Basic)-7.61p-2.14p0.45p0.45p1.11p
Earnings per Share (Diluted)-7.61p-2.14p0.43p0.45p1.05p
Earnings per Share (Adjusted)-7.61p-2.14p0.45p0.45p1.11p
Continuing and Discontinued EPS     
Earnings per Share (Basic)-7.61p-2.14p0.45p0.45p1.11p
Earnings per Share (Diluted)-7.61p-2.14p0.43p0.45p1.05p
Earnings per Share (Adjusted)-7.61p-2.14p0.45p0.45p1.11p
      
Dividend per Sharen/apn/apn/apn/apn/ap
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet29-06-202329-06-202230-06-202129-06-202130-06-2020
Non-Current Assets     
Intangible Assets4.405.044.754.754.74
Property, Plant and Equipment23.9820.1919.7219.7220.42
Investments5.815.965.765.765.90
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assetsn/an/an/an/an/a
Total Non-Current Assets34.1931.1930.2330.2331.05
      
Current Assets     
Inventories11.5911.4110.8410.8410.13
Trade and Other Receivables7.7710.476.226.228.08
Cash at Bank and in Hand14.8520.5240.2740.2736.96
Current Asset Investmentsn/an/an/an/an/a
Other Current Assetsn/an/a0.520.52n/a
Total Current Assets34.2142.3957.8657.8655.17
      
Other Assetsn/an/an/an/an/a
Total Assets68.4073.5888.0988.0986.22
      
Current Liabilities     
Borrowings1.802.271.761.762.26
Other Current Liabilities17.2515.7916.4816.4815.96
Total Current Liabilities19.0618.0518.2318.2318.23
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings34.608.269.429.429.91
Provisions0.490.550.620.620.77
Other Non-Current Liabilities19.048.3211.2911.2913.53
Total Non-Current Liabilities54.1317.1321.3221.3224.21
      
Net Assets-4.7838.4048.5348.5343.78
      
Capital and Reserves     
Share Capital0.690.650.650.650.65
Share Premium Account119.03112.58112.58112.58112.58
Other Reserves44.2243.0842.7142.7143.52
Retained Earnings-168.72-117.91-107.40-107.40-112.96
Shareholders Funds-4.7838.4048.5348.5343.78
      
Minority Interests / Other Equityn/an/an/an/an/a
Total Equity-4.7838.4048.5348.5343.78
      
 29-06-202329-06-202230-06-202129-06-202130-06-2020
Operating Margin-59.27%-16.83%4.78%4.78%10.63%
Return on Capital Employed-130.39%-27.55%7.25%7.25%15.98%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/an/a55.6055.6012.60
PEGn/an/an/an/a0.10
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share-1.35p4.91p6.82p6.45p6.08p